Synopsis
Synopsis
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1-(isopropoxycarbonyloxy)ethyl-7-(2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido)-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo(4,2,0)-oct-2-ene-2-carboxylate
2. Cephalosporin 807
3. Cs 807
4. Cs-807
5. Doxef
6. U 76252
7. U-76,252
8. Vantin
1. Vantin
2. Banan
3. 87239-81-4
4. Orelox
5. Doxef
6. Cs-807
7. Simplicef
8. Otreon
9. U-76252
10. Podomexef
11. Chebi:3505
12. 2tb00a1z7n
13. Cefodox
14. Nsc-759161
15. (rs)-1-((isopropoxycarbonyl)oxy)ethyl (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)-2-((z)-methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
16. Dsstox_cid_2766
17. Dsstox_rid_76722
18. Cefpodoxime 1-(isopropyloxycarbonyloxy)ethyl Ester
19. Dsstox_gsid_22766
20. Xtum-o
21. 1-{[(propan-2-yloxy)carbonyl]oxy}ethyl (6r,7r)-7-{[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
22. 1-{[(propan-2-yloxy)carbonyl]oxy}ethyl 7beta-[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-3,4-didehydrocepham-4-carboxylate
23. Cas-87239-81-4
24. Simplicef [veterinary]
25. Unii-2tb00a1z7n
26. Orelox Paed
27. Ncgc00164598-01
28. Ncgc00183131-01
29. Mfcd00865088
30. Vantin (tn)
31. Cefpodoxime Proxetil [usan:usp:jan]
32. Schembl27071
33. Mls001401428
34. Chembl1201016
35. Dtxsid1022766
36. Cefpodoxime (as Proxetil)
37. Cefpodoxime Proxetil (jp17/usp)
38. Cefpodoxime Proxetil [jan]
39. Hms3715j22
40. Cefpodoxime Proxetil [usan]
41. Cefpodoxime Proxetil, Vantin
42. Hy-n7101
43. Cefpodoxime Proxetil [vandf]
44. Tox21_113377
45. Tox21_113428
46. Bdbm50248233
47. Cefpodoxime Proxetil [mart.]
48. S5350
49. Cefpodoxime Proxetil [usp-rs]
50. Cefpodoxime Proxetil [who-dd]
51. Akos015994692
52. Ccg-221250
53. Ks-1149
54. Nsc 759161
55. Cefpodoxime Proxetil [green Book]
56. (+-)-1-hydroxyethyl (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(z)-(o-methyloxime), Isopropyl Carbonate (ester)
57. Cefpodoxime Proxetil [orange Book]
58. Ru-51807
59. Smr000469193
60. Cefpodoxime Proxetil [ep Monograph]
61. Cefpodoxime Proxetil [usp Impurity]
62. Cefpodoxime Proxetil [usp Monograph]
63. Cefpodoxime Proxetil For Peak Identification
64. Cs-0027614
65. C08115
66. D00920
67. Ab01209734-01
68. 239c814
69. A842048
70. Cefpodoxime Proxetil For Impurity H Identification
71. Cefpodoxime 1-(isopropoxycarbonyloxy)ethyl Ester
72. Cefpodoxime 1-(isopropoxycarbonyloxy)ethyl Ester [mi]
73. (+/-)-1-hydroxyethyl (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7 (sup 2)-(z)-(o-methyloxime), Isopropyl Carbonate (ester)
74. (6r,7r)-1-((isopropoxycarbonyl)oxy)ethyl 7-((z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
75. (6r,7r)-7-(((2z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid 1-(((1-methylethoxy)carbonyl)oxy)ethyl Ester
76. 1-({[(1-methylethyl)oxy]carbonyl}oxy)ethyl (6r,7r)-7-({(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-[(methyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
77. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, 1-(((1-methylethoxy)carbonyl)oxy)ethyl Ester, (6r-(6.alpha.,7.beta.(z)))-
78. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, 1-(((1-methylethoxy)carbonyl)oxy)ethyl Ester, (6r-(6alpha,7beta(z)))-
79. 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, 7-[[(2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, 1-[[(1-methylethoxy)carbonyl]oxy]ethyl Ester, (6r,7r)-
| Molecular Weight | 557.6 g/mol |
|---|---|
| Molecular Formula | C21H27N5O9S2 |
| XLogP3 | 0.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 13 |
| Exact Mass | 557.12501980 g/mol |
| Monoisotopic Mass | 557.12501980 g/mol |
| Topological Polar Surface Area | 235 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 976 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 2 | |
|---|---|
| Drug Name | Cefpodoxime proxetil |
| PubMed Health | Cefpodoxime Proxetil (By mouth) |
| Drug Classes | Antibiotic |
| Drug Label | Cefpodoxime proxetil is an orally administered, extended spectrum, semi-synthetic antibiotic of the cephalosporin class. The chemical name is (RS)-1(isopropoxycarbonyloxy) ethyl (+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-{(Z)methoxyimino}acetamido]-3-m... |
| Active Ingredient | Cefpodoxime proxetil |
| Dosage Form | Tablet; For suspension |
| Route | Oral |
| Strength | eq 100mg base; eq 200mg base; eq 100mg base/5ml; eq 50mg base/5ml |
| Market Status | Prescription |
| Company | Ranbaxy; Aurobindo Pharma; Sandoz; Orchid Hlthcare |
| 2 of 2 | |
|---|---|
| Drug Name | Cefpodoxime proxetil |
| PubMed Health | Cefpodoxime Proxetil (By mouth) |
| Drug Classes | Antibiotic |
| Drug Label | Cefpodoxime proxetil is an orally administered, extended spectrum, semi-synthetic antibiotic of the cephalosporin class. The chemical name is (RS)-1(isopropoxycarbonyloxy) ethyl (+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-{(Z)methoxyimino}acetamido]-3-m... |
| Active Ingredient | Cefpodoxime proxetil |
| Dosage Form | Tablet; For suspension |
| Route | Oral |
| Strength | eq 100mg base; eq 200mg base; eq 100mg base/5ml; eq 50mg base/5ml |
| Market Status | Prescription |
| Company | Ranbaxy; Aurobindo Pharma; Sandoz; Orchid Hlthcare |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API SUPPLIERS
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-03-09
Pay. Date : 2020-01-21
DMF Number : 34502
Submission : 2020-02-17
Status : Active
Type : II
Certificate Number : CEP 2020-399 - Rev 01
Issue Date : 2025-01-03
Type : Chemical
Substance Number : 2341
Status : Valid
Registration Number : 303MF10058
Registrant's Address : No. 849 Dongjia Town, Licheng District, Jinan, Shandong, China
Initial Date of Registration : 2021-04-02
Latest Date of Registration :
NDC Package Code : 51810-052
Start Marketing Date : 2022-06-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Seongi Bio Co., Ltd.
Registration Date : 2022-07-01
Registration Number : 20200618-25-A-359-12(1)
Manufacturer Name : Qilu Antibiotics Pharmaceutical Co., Ltd.
Manufacturer Address : No.849 Dongjia Town, Licheng District, Jinan, Shandong Province, China
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20076
Submission : 2006-12-26
Status : Active
Type : II
Certificate Number : R0-CEP 2013-064 - Rev 00
Issue Date : 2013-09-30
Type : Chemical
Substance Number : 2341
Status : Withdrawn by Holder
Registrant Name : Lee Sung International Co., Ltd.
Registration Date : 2014-06-11
Registration Number : 20140611-25-A-300-07
Manufacturer Name : Sandoz GmbH
Manufacturer Address : Biochemiestraβe 10, 6250 Kundl, Austria
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-02-27
Pay. Date : 2016-12-27
DMF Number : 29791
Submission : 2015-09-14
Status : Active
Type : II
Date of Issue : 2019-09-03
Valid Till : 2022-09-03
Written Confirmation Number : WC-0190
Address of the Firm :
NDC Package Code : 61788-5000
Start Marketing Date : 2004-05-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Youngjin Pharmaceutical Co., Ltd.
Registration Date : 2017-08-03
Registration Number : 20150410-25-A-305-10(1)
Manufacturer Name : Covalent Laboratories Pvt. Ltd
Manufacturer Address : Sy. No.374, Gundla Machanoor Village, Hathnoor Mandal, Sangareddy District - 502 296, Telangana State,
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18505
Submission : 2005-07-11
Status : Active
Type : II
Registration Number : 306MF10078
Registrant's Address : Plot No. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Alathur, Chengalpattu District-603 110, Tamilnadu, INDIA.
Initial Date of Registration : 2024-06-12
Latest Date of Registration :
Date of Issue : 2019-07-22
Valid Till : 2022-07-21
Written Confirmation Number : WC-0131
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23572
Submission : 2010-02-23
Status : Active
Type : II
Date of Issue : 2022-05-17
Valid Till : 2025-05-16
Written Confirmation Number : WC-0008
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16542
Submission : 2003-04-15
Status : Inactive
Type : II
Certificate Number : R1-CEP 2010-283 - Rev 01
Issue Date : 2017-12-05
Type : Chemical
Substance Number : 2341
Status : Valid
Registration Number : 225MF10129
Registrant's Address : Biochemiesstrasse 10,6250 Kundl, Austria
Initial Date of Registration : 2013-07-09
Latest Date of Registration :
Registrant Name : HKINNOEN Co., Ltd.
Registration Date : 2014-07-25
Registration Number : 20140611-25-A-300-07(1)
Manufacturer Name : Sandoz GmbH
Manufacturer Address : Biochemiestraβe 10, 6250 Kundl, Austria
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6937
Submission : 1987-04-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9886
Submission : 1987-04-15
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
Certificate Number : R0-CEP 2012-166 - Rev 02
Status : Withdrawn by Holder
Issue Date : 2016-06-22
Type : Chemical
Substance Number : 2341
Certificate Number : R1-CEP 2015-146 - Rev 00
Status : Valid
Issue Date : 2022-04-14
Type : Chemical
Substance Number : 2341
Certificate Number : R1-CEP 2015-354 - Rev 00
Status : Suspended by EDQM GMP non-compliance
Issue Date : 2022-08-01
Type : Chemical
Substance Number : 2341
Cefpodoxime Proxetil, Process 3
Certificate Number : CEP 2020-399 - Rev 01
Status : Valid
Issue Date : 2025-01-03
Type : Chemical
Substance Number : 2341
Certificate Number : CEP 2017-030 - Rev 01
Status : Valid
Issue Date : 2023-10-09
Type : Chemical
Substance Number : 2341
Cefpodoxime Proxetil, Process 2
Certificate Number : R0-CEP 2019-319 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2020-09-21
Type : Chemical
Substance Number : 2341
Certificate Number : R1-CEP 2010-283 - Rev 01
Status : Valid
Issue Date : 2017-12-05
Type : Chemical
Substance Number : 2341
Cefpodoxime Proxetil, Turbhe Site
Certificate Number : R0-CEP 2013-064 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2013-09-30
Type : Chemical
Substance Number : 2341
Certificate Number : R0-CEP 2010-186 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2013-08-08
Type : Chemical
Substance Number : 2341
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : CEP 2011-165 - Rev 02
Status : Valid
Issue Date : 2025-01-20
Type : Chemical
Substance Number : 2341
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] JDMF
Registration Number : 301MF10023
Registrant's Address : Village Saidpura, Tehsil Dera Bassi, District Sahibzada Ajit Singh Nagar-140 507, Pun...
Initial Date of Registration : 2019-06-28
Latest Date of Registration : 2019-06-28
Registration Number : 306MF10078
Registrant's Address : Plot No. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Alathur, Cheng...
Initial Date of Registration : 2024-06-12
Latest Date of Registration : 2024-06-12
Registration Number : 223MF10157
Registrant's Address : S. C. O. 99-100, 3rd & 4th Floor, Sector 17-B, Chandigarh-160017, INDIA
Initial Date of Registration : 2011-11-02
Latest Date of Registration : 2011-11-02
Registration Number : 303MF10058
Registrant's Address : No. 849 Dongjia Town, Licheng District, Jinan, Shandong, China
Initial Date of Registration : 2021-04-02
Latest Date of Registration : 2023-08-09
Registration Number : 225MF10129
Registrant's Address : Biochemiesstrasse 10,6250 Kundl, Austria
Initial Date of Registration : 2013-07-09
Latest Date of Registration : 2013-07-09
Registration Number : 222MF10026
Registrant's Address : Plot No. 90, Sector 32, Gurgaon, Haryana 122011, India
Initial Date of Registration : 2010-01-22
Latest Date of Registration : 2010-01-22
Registration Number : 227MF10122
Registrant's Address : 13, Olympic-ro 35da-gil, Songpa-gu, Seoul, Korea
Initial Date of Registration : 2015-04-22
Latest Date of Registration : 2015-04-22
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Thickeners and Stabilizers
Controlled & Modified Release
Disintegrants & Superdisintegrants
Direct Compression
Granulation
Lubricants & Glidants
Taste Masking
Film Formers & Plasticizers
Co-Processed Excipients
Rheology Modifiers
Chewable & Orodispersible Aids
Solubilizers
Emulsifying Agents
Parenteral
Empty Capsules
API Stability Enhancers
Vegetarian Capsules
Coloring Agents
Topical
Surfactant & Foaming Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
88
PharmaCompass offers a list of Cefpodoxime Proxetil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cefpodoxime Proxetil manufacturer or Cefpodoxime Proxetil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefpodoxime Proxetil manufacturer or Cefpodoxime Proxetil supplier.
PharmaCompass also assists you with knowing the Cefpodoxime Proxetil API Price utilized in the formulation of products. Cefpodoxime Proxetil API Price is not always fixed or binding as the Cefpodoxime Proxetil Price is obtained through a variety of data sources. The Cefpodoxime Proxetil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cefpodoximum manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefpodoximum, including repackagers and relabelers. The FDA regulates Cefpodoximum manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefpodoximum API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cefpodoximum manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cefpodoximum supplier is an individual or a company that provides Cefpodoximum active pharmaceutical ingredient (API) or Cefpodoximum finished formulations upon request. The Cefpodoximum suppliers may include Cefpodoximum API manufacturers, exporters, distributors and traders.
click here to find a list of Cefpodoximum suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cefpodoximum DMF (Drug Master File) is a document detailing the whole manufacturing process of Cefpodoximum active pharmaceutical ingredient (API) in detail. Different forms of Cefpodoximum DMFs exist exist since differing nations have different regulations, such as Cefpodoximum USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cefpodoximum DMF submitted to regulatory agencies in the US is known as a USDMF. Cefpodoximum USDMF includes data on Cefpodoximum's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cefpodoximum USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cefpodoximum suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cefpodoximum Drug Master File in Japan (Cefpodoximum JDMF) empowers Cefpodoximum API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cefpodoximum JDMF during the approval evaluation for pharmaceutical products. At the time of Cefpodoximum JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cefpodoximum suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cefpodoximum Drug Master File in Korea (Cefpodoximum KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cefpodoximum. The MFDS reviews the Cefpodoximum KDMF as part of the drug registration process and uses the information provided in the Cefpodoximum KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cefpodoximum KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cefpodoximum API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cefpodoximum suppliers with KDMF on PharmaCompass.
A Cefpodoximum CEP of the European Pharmacopoeia monograph is often referred to as a Cefpodoximum Certificate of Suitability (COS). The purpose of a Cefpodoximum CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cefpodoximum EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cefpodoximum to their clients by showing that a Cefpodoximum CEP has been issued for it. The manufacturer submits a Cefpodoximum CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cefpodoximum CEP holder for the record. Additionally, the data presented in the Cefpodoximum CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cefpodoximum DMF.
A Cefpodoximum CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cefpodoximum CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cefpodoximum suppliers with CEP (COS) on PharmaCompass.
A Cefpodoximum written confirmation (Cefpodoximum WC) is an official document issued by a regulatory agency to a Cefpodoximum manufacturer, verifying that the manufacturing facility of a Cefpodoximum active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cefpodoximum APIs or Cefpodoximum finished pharmaceutical products to another nation, regulatory agencies frequently require a Cefpodoximum WC (written confirmation) as part of the regulatory process.
click here to find a list of Cefpodoximum suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cefpodoximum as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cefpodoximum API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cefpodoximum as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cefpodoximum and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cefpodoximum NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cefpodoximum suppliers with NDC on PharmaCompass.
Cefpodoximum Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefpodoximum GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cefpodoximum GMP manufacturer or Cefpodoximum GMP API supplier for your needs.
A Cefpodoximum CoA (Certificate of Analysis) is a formal document that attests to Cefpodoximum's compliance with Cefpodoximum specifications and serves as a tool for batch-level quality control.
Cefpodoximum CoA mostly includes findings from lab analyses of a specific batch. For each Cefpodoximum CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefpodoximum may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefpodoximum EP), Cefpodoximum JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefpodoximum USP).
